Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -630.65K | 433.23K | 197.42K |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---630.65K | --433.23K | --197.42K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 1,480.39%1.21M | 3,347.82%1.93M | 234.36%749.66K | 243.88%889.89K | 10.81%213.18K | -53.14%76.4K | -98.23%55.95K | -120.93%-557.95K | 14.77%258.78K | 98.29%192.38K |
| Selling and administrative expenses | 2,612.61%1.18M | 199.56%1.9M | 998.47%1.61M | -52.50%99.88K | -4.60%117.93K | -58.70%43.42K | -80.31%634.08K | -94.75%146.73K | 4.19%210.25K | 69.76%123.61K |
| -Selling and marketing expense | 58.07%6.27K | -55.97%26.67K | 119.27%14.44K | -89.11%2.06K | -62.84%6.22K | -78.43%3.97K | -79.31%60.57K | -93.81%6.59K | -84.78%18.87K | -23.38%16.73K |
| -General and administrative expense | 2,869.40%1.17M | 226.55%1.87M | 1,039.78%1.6M | -48.88%97.83K | 4.52%111.71K | -54.52%39.46K | -80.41%573.51K | -94.78%140.14K | 145.88%191.38K | 109.64%106.88K |
| Depreciation amortization depletion | --273 | ---- | ---- | --0 | 83.15%88.65K | ---- | ---- | ---- | 70.01%40.25K | 100.00%48.4K |
| -Depreciation and amortization | --273 | ---- | ---- | --0 | 83.15%88.65K | ---- | ---- | ---- | 70.01%40.25K | 100.00%48.4K |
| Other operating expenses | -11.01%29.35K | 105.13%29.64K | -25.55%-773.44K | 9,440.04%790.01K | -67.61%6.6K | -43.05%32.98K | -956.08%-578.13K | ---616.02K | --8.28K | --20.37K |
| Operating profit | -1,480.39%-1.21M | -3,347.82%-1.93M | -931.10%-749.66K | -610.12%-889.89K | -4,328.82%-213.18K | 53.14%-76.4K | 98.23%-55.95K | 97.27%-72.71K | 177.37%174.45K | 105.20%5.04K |
| Net non-operating interest income (expenses) | -64.07%-581.39K | -62.49%-263.9K | -48.25%-83.72K | -106.73%-163.86K | -24.37%-69.91K | 21.48%-354.35K | 33.24%-162.41K | 17.96%-56.47K | -14.51%-79.26K | |
| Non-operating interest expense | ---- | 64.07%581.39K | 62.49%263.9K | 48.25%83.72K | 106.73%163.86K | 24.37%69.91K | -21.48%354.35K | -33.24%162.41K | -17.96%56.47K | 14.51%79.26K |
| Other net income (expenses) | -42,886.38%-296.61K | -1,619.68%-426.57K | 177.20%31.78K | -119.29%-6.58K | 224.11%101.03K | 99.90%-690 | 94.93%-24.81K | -548.24%-41.16K | 116.30%34.1K | |
| Gain on sale of security | ---- | ---- | ---- | 177.20%31.78K | -119.29%-6.58K | 224.11%101.03K | 95.31%-14.89K | 90.73%-39.01K | -548.24%-41.16K | 116.30%34.1K |
| Special income (charges) | ---- | -199.78%-320.24K | ---- | ---- | ---- | ---- | 1,222.03%320.95K | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --587.75K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | 16.65%-267.51K | ---- | ---- | ---- | ---- | -1,222.03%-320.95K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | 107.70%23.63K | ---- | ---- | ---- | ---- | 18.14%-306.75K | ---- | ---- | ---- |
| Income before tax | -2,566.44%-1.21M | -583.01%-2.81M | -454.07%-1.44M | -1,326.10%-941.84K | -856.19%-383.61K | 75.92%-45.28K | 90.41%-411K | 92.36%-259.92K | 125.55%76.82K | 89.32%-40.12K |
| Income tax | 0 | 0 | 0 | 0 | 0 | |||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2,566.44%-1.21M | -583.01%-2.81M | -454.07%-1.44M | -1,326.10%-941.84K | -856.19%-383.61K | 75.92%-45.28K | 90.41%-411K | 92.36%-259.92K | 125.55%76.82K | 89.32%-40.12K |
| Net income continuous operations | -2,566.44%-1.21M | -583.01%-2.81M | -454.07%-1.44M | -1,326.10%-941.84K | -856.19%-383.61K | 75.92%-45.28K | 90.41%-411K | 92.36%-259.92K | 125.55%76.82K | 89.32%-40.12K |
| Noncontrolling interests | -5.94%507 | -4.28K | 272.76%539 | |||||||
| Net income attributable to the company | -2,536.18%-1.21M | -583.01%-2.81M | -454.07%-1.44M | -1,326.10%-941.84K | -845.53%-379.34K | 75.60%-45.82K | 90.41%-411K | 92.36%-259.92K | 125.55%76.82K | 89.32%-40.12K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2,536.18%-1.21M | -583.01%-2.81M | -454.07%-1.44M | -1,326.10%-941.84K | -845.53%-379.34K | 75.60%-45.82K | 90.41%-411K | 92.36%-259.92K | 125.55%76.82K | 89.32%-40.12K |
| Diluted earnings per share | 0 | -150.00%-4 | -31.75%-1.0143 | -1,016.67%-2.117 | -779.98%-1.0614 | 0 | 90.00%-1.6 | 92.47%-0.7699 | 125.55%0.2309 | 89.32%-0.1206 |
| Basic earnings per share | 0 | -150.00%-4 | -31.75%-1.0143 | -1,016.67%-2.117 | -779.98%-1.0614 | 0 | 90.00%-1.6 | 92.47%-0.7699 | 125.55%0.2309 | 89.32%-0.1206 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.